PHOENIX BIOSYSTEM, INC.
PLEASANTON, CA · Medtech · Private
Point-of-care HPV DNA diagnostic test using PENN-RAMP isothermal molecular assay technology
- Grants
- $1.9M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $3.2M
- 8 awards · Defense, Health and Human S
- #164 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20082010201220142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · SBIR Phase 1 | $847,790 | |
| Federal contract | Department of Health and Human Services · R&d-drug Dependency-mgmt Sup | $182,527 | |
| Federal contract | Department of Health and Human Services · TAS::75 0872::TAS - Advanced Liquid Logic | $145,584 | |
| Federal contract | Department of Defense · Phase I, Erms: 10019005 | $99,368 | |
| Federal contract | Department of Health and Human Services · Multiplexed Biosensor For Detecting Low Abundance Cancer | $196,467 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Multiplexed Biosensor For Detecting Low Abundance Cancer-related Proteins/peptides | $999,816 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of biomarker panels for point-of-care assessment of sleep disorders | $149,361 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid Nucleic Acid Test for Chlamydia in Resource Limited Settings | $222,674 | |
| Federal grant | Department of Health and Human Services · Phase I · Point Of Care Hiv Combo Assay | $222,768 | |
| Federal grant | Department of Health and Human Services · Phase I · Multiplexed Point Of Care Nucleic Acid Assay for STI | $197,942 | |
| Federal grant | Department of Health and Human Services · Phase I · Multiplexed Point Of Care Nucleic Acid Assay for STI | $202,058 | |
| Federal grant | Department of Health and Human Services · Phase II · Low cost, automated smartphone based assay for semen analysis | $219,062 | |
| Federal grant | Department of Health and Human Services · Phase II · Low cost, automated smartphone based assay for semen analysis | $1 | |
| Federal contract | Department of Health and Human Services · Rapid Point Of Care Molecular Diagnostics For Hcv | $299,957 | |
| Federal contract | Department of Health and Human Services · Hpv Point Of Care Molecular Diagnostics For Lmics | $382,034 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 161 | NEUWAVE MEDICAL, INC. | $3.3M | $51M |
| 162 | MIMOSA ACOUSTICS | $3.3M | — |
| 163 | NEUROFIT, INC. | $3.2M | — |
| 164 | PHOENIX BIOSYSTEM, INC. | $3.2M | — |
| 165 | MIRAVISTA DIAGNOSTICS LLC | $3.1M | — |
| 166 | SENSIMETRICS CORP | $3.1M | — |
| 167 | SHERLOCK BIOSCIENCES, INC. | $3.1M | $113M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.